SCHEMBL9988071

SCHEMBL9988071

Oc1cccc(-c2[c]ccc(-c3cccc(Cl)c3)c2O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
ALOX5 P09917 1/20 0.42
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
MIF P14174 1/20 0.40
EGFR P00533 3/20 0.39
HSD17B1 P14061 3/20 0.38
HSD17B2 P37059 3/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CHEK1 O14757 1/20 0.38
WEE1 P30291 1/20 0.38
PIK3CA P42336 2/20 0.36
ESR2 Q92731 1/20 0.36
ABL1 P00519 1/20 0.36
ABL2 P42684 1/20 0.36
SRC P12931 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10413690 0.78 ALOX5 (0.42) TSHRALOX5CHEK1ESR2
SCHEMBL1029061 0.75 TSHR (0.73) TSHRALOX5CA12CA9HSD17B1
SCHEMBL4281937 0.73 HSD17B1 (0.48) TSHRHSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL4280216 0.73 HSD17B1 (0.44) TSHRCA12CA9HSD17B1HSD17B2
SCHEMBL4289202 0.71 TSHR (0.50) TSHRALOX5CA12CA9HSD17B1
SCHEMBL16719910 0.71 ALOX5 (0.55) TSHRALOX5EGFRPIK3CAESR2
SCHEMBL9769410 0.71 HSD17B1 (0.45) TSHRCA12CA9HSD17B1HSD17B2
SCHEMBL4289108 0.71 HSD17B1 (0.41) TSHRHSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL16720511 0.70 KDM1A (0.43) CA12HSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL21296916 0.69 HSD17B1 (0.62) TSHRALOX5CA12CA9HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397462-A2 Compounds, compositions and methods of treatment for heart failure Cytokinetics, Inc. (US) 2011-12-21 EP claimed